Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.07% | -8.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.07% | -8.52% | |||
| Cost of Revenue | -0.07% | -26.79% | |||
| Gross Profit | -0.07% | 50.32% | |||
| SG&A Expenses | -0.07% | -19.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 0.07% | -140.79% | |||
| Total Operating Expenses | -0.07% | -33.38% | |||
| Operating Income | -0.07% | 3,037.77% | |||
| Income Before Tax | 0.08% | -394.04% | |||
| Income Tax Expenses | 0.08% | -249.55% | |||
| Earnings from Continuing Operations | -0.09% | 195.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -0.08% | 195.02% | |||
| Net Income | -0.08% | 195.24% | |||
| EBIT | -0.07% | 3,037.77% | |||
| EBITDA | -0.07% | 771.20% | |||
| EPS Basic | 0.00% | 183.33% | |||
| Normalized Basic EPS | 0.00% | 450.00% | |||
| EPS Diluted | 0.00% | 183.33% | |||
| Normalized Diluted EPS | 0.00% | 450.00% | |||
| Average Basic Shares Outstanding | 0.00% | 4.31% | |||
| Average Diluted Shares Outstanding | 0.00% | 4.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||